Guided Therapeutics (GTHP) Total Current Liabilities (2010 - 2025)
Guided Therapeutics recorded quarterly Total Current Liabilities of $6.6 million in Q4 2025, up 2.57% quarter-over-quarter from $6.5 million in Q3 2025, and up 7.81% year-over-year from $6.2 million in Q4 2024.
Guided Therapeutics' Total Current Liabilities history runs 16 years deep, the most recent figure standing at $6.6 million for Q4 2025.
- In Q4 2025, Total Current Liabilities rose 7.81% year-over-year to $6.6 million; the TTM figure through Dec 2025 stood at $6.6 million (up 7.81% YoY), while the FY2025 annual figure was $6.6 million, up 7.81% from the prior year.
- Total Current Liabilities came in at $6.6 million for Q4 2025 at Guided Therapeutics, up from $6.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $9.2 million in Q1 2021 to a low of $4.0 million in Q1 2023.
- A 5-year average of $5.7 million and a median of $5.7 million in 2021 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities slumped 40.96% in 2022 and soared 33.45% in 2024, its largest moves.
- Guided Therapeutics' Total Current Liabilities stood at $5.7 million in 2021, then fell by 14.49% to $4.9 million in 2022, then decreased by 1.23% to $4.8 million in 2023, then increased by 27.99% to $6.2 million in 2024, then rose by 7.81% to $6.6 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $6.6 million, $6.5 million, and $6.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 6.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.64 Mn |
| Sep 30, 2025 | 6.47 Mn |
| Jun 30, 2025 | 6.38 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 6.16 Mn |
| Sep 30, 2024 | 6.03 Mn |
| Jun 30, 2024 | 5.73 Mn |
| Mar 31, 2024 | 5.34 Mn |
| Dec 31, 2023 | 4.81 Mn |
| Sep 30, 2023 | 4.83 Mn |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 4.87 Mn |
| Sep 30, 2022 | 5.15 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Mar 31, 2022 | 5.45 Mn |
| Dec 31, 2021 | 5.69 Mn |
| Sep 30, 2021 | 5.08 Mn |
| Jun 30, 2021 | 5.67 Mn |
| Mar 31, 2021 | 9.23 Mn |
| Dec 31, 2020 | 8.96 Mn |
| Sep 30, 2020 | 8.31 Mn |
| Jun 30, 2020 | 8.63 Mn |
| Mar 31, 2020 | 9.22 Mn |
| Dec 31, 2019 | 12.41 Mn |
| Sep 30, 2019 | 11.63 Mn |
| Jun 30, 2019 | 11.74 Mn |
| Mar 31, 2019 | 11.69 Mn |
| Dec 31, 2018 | 10.99 Mn |
| Sep 30, 2018 | 10.67 Mn |
| Jun 30, 2018 | 12.56 Mn |
| Mar 31, 2018 | 12.19 Mn |
| Dec 31, 2017 | 11.85 Mn |
| Sep 30, 2017 | 11.42 Mn |
| Jun 30, 2017 | 10.78 Mn |
| Mar 31, 2017 | 9.70 Mn |
| Dec 31, 2016 | 9.34 Mn |
| Sep 30, 2016 | 8.55 Mn |
| Jun 30, 2016 | 7.96 Mn |
| Mar 31, 2016 | 6.03 Mn |
| Dec 31, 2015 | 5.47 Mn |
| Sep 30, 2015 | 4.96 Mn |
| Jun 30, 2015 | 4.79 Mn |
| Mar 31, 2015 | 5.17 Mn |
| Dec 31, 2014 | 4.60 Mn |
| Sep 30, 2014 | 4.12 Mn |
| Jun 30, 2014 | 2.51 Mn |
| Mar 31, 2014 | 2.76 Mn |
| Dec 31, 2013 | 1.77 Mn |
| Sep 30, 2013 | 1.61 Mn |
| Jun 30, 2013 | 1.62 Mn |
| Mar 31, 2013 | 1.54 Mn |
| Dec 31, 2012 | 2.35 Mn |
| Sep 30, 2012 | 2.65 Mn |
| Jun 30, 2012 | 3.08 Mn |
| Mar 31, 2012 | 2.18 Mn |
| Dec 31, 2011 | 2.73 Mn |
| Jun 30, 2011 | 2.89 Mn |
| Dec 31, 2010 | 2.77 Mn |